Saracatinib

  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals1

Outcomes

1

Atherosclerosis

downin mice1

1 study
  1. Saracatinib protects against atherosclerosis in mice.

    “saracatinib, a specific Src inhibitor, has been demonstrated to effectively alleviate diabetic atherosclerosis in experimental settings.”

    Animalsin experimental settings

    Lactate-Activated GPR132-Src Signal Induces Macrophage Senescence and Aggravates Atherosclerosis Under Diabetes

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)10 Jun 2025

More on Atherosclerosis

Latest